Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk

Lung Cancer

Volumn 56, Issue 1, 2007, Pages 1-7

  Falvella, F Stefania ^a   Spinola, Monica ^a   Manenti, Giacomo ^a   Conti, Barbara ^a   Pastorino, Ugo ^a   Skaug, Vidar ^b   Haugen, Aage ^b   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

DEC2; Genetic predisposition; KRAS; Lung cancer; SHARP 1

Indexed keywords

ALANINE; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; VALINE;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INTRON; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33847689405     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.11.008     Document Type: Article

References (25)

1. To M.D., Perez-Losada J., Mao J.H., Hsu J., Jacks T., and Balmain A. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat Genet 38 (2006) 926-930
2. Manenti G., Galbiati F., Giannì Barrera R., Pettinicchio A., Acevedo A., and Dragani T.A. Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Oncogene 23 (2004) 4495-4504
3. Gariboldi M., Manenti G., Canzian F., Falvella F.S., Radice M.T., Pierotti M.A., et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat Genet 3 (1993) 132-136
4. Dragani T.A., Hirohashi S., Juji T., Kawajiri K., Kihara M., Ono-Kihara M., et al. Population-based mapping of pulmonary adenoma susceptibility 1 (Pas1) locus. Cancer Res 60 (2000) 5017-5020
5. Yanagitani N., Kohno T., Sunaga N., Kunitoh H., Tamura T., Tsuchiya S., et al. Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12. 1. Carcinogenesis 23 (2002) 1177-1183
6. Abecasis G.R., Noguchi E., Heinzmann A., Traherne J.A., Bhattacharyya S., Leaves N.I., et al. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 68 (2001) 191-197
7. Falvella F.S., Manenti G., Spinola M., Pignatiello C., Conti B., Pastorino U., et al. Identification of RASSF8 as a candidate lung tumor suppressor gene. Oncogene (2006) 3934-3938
8. Heidenblad M., Jonson T., Mahlamaki E.H., Gorunova L., Karhu R., Johansson B., et al. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification. Genes Chromosomes Cancer 34 (2002) 211-223
9. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., et al. New genes involved in cancer identified by retroviral tagging. Nat Genet 32 (2002) 166-174
10. Zienolddiny S., Campa D., Lind H., Ryberg D., Skaug V., Stangeland L., et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27 (2006) 560-567
11. Stanssens P., Zabeau M., Meersseman G., Remes G., Gansemans Y., Storm N., et al. High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res 14 (2004) 126-133
12. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 (1995) 311-322
13. Dupont W.D., and Plummer Jr. W.D. Power and sample size calculations. A review and computer program. Contr Clin Trials 11 (1990) 116-128
14. Weir B.S. Genetic data analysis. 2. Methods for discrete population genetic data (1996), Sinauer Associates, Inc., Sunderlands
15. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 3 (1958) 457-481
16. Peto R., and Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc [A] 135 (1972) 185-206
17. Manenti G., De Gregorio L., Pilotti S., Falvella F.S., Incarbone M., Ravagnani F., et al. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis 18 (1997) 1917-1920
18. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., and Lander E.S. High-resolution haplotype structure in the human genome. Nat Genet 29 (2001) 229-232
19. Wall J.D., and Pritchard J.K. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4 (2003) 587-597
20. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
21. Vieland V.J. The replication requirement. Nat Genet 29 (2001) 244-245
22. Davis R.L., and Turner D.L. Vertebrate hairy and enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 20 (2001) 8342-8357
23. Iso T., Kedes L., and Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194 (2003) 237-255
24. Allenspach E.J., Maillard I., Aster J.C., and Pear W.S. Notch signaling in cancer. Cancer Biol Ther 1 (2002) 466-476
25. Sun H., Lu B., Li R.Q., Flavell R.A., and Taneja R. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat Immunol 2 (2001) 1040-1047